These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7497597)

  • 1. Modulation of the in vitro cardiotoxicity of doxorubicin by flavonoids.
    Hüsken BC; de Jong J; Beekman B; Onderwater RC; van der Vijgh WJ; Bast A
    Cancer Chemother Pharmacol; 1995; 37(1-2):55-62. PubMed ID: 7497597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of different iron chelators as protective agents against acute doxorubicin-induced cardiotoxicity.
    Voest EE; van Acker SA; van der Vijgh WJ; van Asbeck BS; Bast A
    J Mol Cell Cardiol; 1994 Sep; 26(9):1179-85. PubMed ID: 7815460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protectors against doxorubicin-induced cardiotoxicity: flavonoids.
    Bast A; Kaiserová H; den Hartog GJ; Haenen GR; van der Vijgh WJ
    Cell Biol Toxicol; 2007 Jan; 23(1):39-47. PubMed ID: 17063376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
    van Acker SA; Boven E; Kuiper K; van den Berg DJ; Grimbergen JA; Kramer K; Bast A; van der Vijgh WJ
    Clin Cancer Res; 1997 Oct; 3(10):1747-54. PubMed ID: 9815559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of (+-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) in modulating free radical scavenging enzymes in doxorubicin-induced cardiomyopathy.
    Alderton P; Gross J; Green MD
    Cancer Res; 1990 Aug; 50(16):5136-42. PubMed ID: 2116226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy.
    Martin E; Thougaard AV; Grauslund M; Jensen PB; Bjorkling F; Hasinoff BB; Tjørnelund J; Sehested M; Jensen LH
    Toxicology; 2009 Jan; 255(1-2):72-9. PubMed ID: 19010377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin-dependent reduction of ferrylmyoglobin and inhibition of lipid peroxidation: implications for cardiotoxicity of anticancer anthracyclines.
    Menna P; Salvatorelli E; Giampietro R; Liberi G; Teodori G; Calafiore AM; Minotti G
    Chem Res Toxicol; 2002 Sep; 15(9):1179-89. PubMed ID: 12230412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural aspects of antioxidant activity of flavonoids.
    van Acker SA; van den Berg DJ; Tromp MN; Griffioen DH; van Bennekom WP; van der Vijgh WJ; Bast A
    Free Radic Biol Med; 1996; 20(3):331-42. PubMed ID: 8720903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the protective effects against chronic doxorubicin cardiotoxicity and the rates of iron (III) displacement reactions of ICRF-187 and other bisdiketopiperazines.
    Herman EH; Zhang J; Hasinoff BB; Chadwick DP; Clark JR; Ferrans VJ
    Cancer Chemother Pharmacol; 1997; 40(5):400-8. PubMed ID: 9272116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hydrolysis product of ICRF-187 promotes iron-catalysed hydroxyl radical production via the Fenton reaction.
    Thomas C; Vile GF; Winterbourn CC
    Biochem Pharmacol; 1993 May; 45(10):1967-72. PubMed ID: 8390256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoids as protectors against doxorubicin cardiotoxicity: role of iron chelation, antioxidant activity and inhibition of carbonyl reductase.
    Kaiserová H; Simůnek T; van der Vijgh WJ; Bast A; Kvasnicková E
    Biochim Biophys Acta; 2007 Sep; 1772(9):1065-74. PubMed ID: 17572073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. dl-N,N'-dicarboxamidomethyl-N,N'-dicarboxymethyl-1,2-diaminopropane (ICRF-198) and d-1,2-bis(3,5-dioxopiperazine-1-yl)propane (ICRF-187) inhibition of Fe3+ reduction, lipid peroxidation, and CaATPase inactivation in heart microsomes exposed to adriamycin.
    Vile GF; Winterbourn CC
    Cancer Res; 1990 Apr; 50(8):2307-10. PubMed ID: 2156615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated mouse atrium as a model to study anthracycline cardiotoxicity: the role of the beta-adrenoceptor system and reactive oxygen species.
    de Jong J; Schoofs PR; Onderwater RC; van der Vijgh WJ; Pinedo HM; Bast A
    Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):275-89. PubMed ID: 2166963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of the protective activity of ICRF-187 against alloxan-induced diabetes in mice.
    el-Hage A; Herman EH; Yang GC; Crouch RK; Ferrans VJ
    Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):341-60. PubMed ID: 3090662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ameliorative effects of ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] on the cardiotoxicity induced by doxorubicin or by isoproterenol in the mouse.
    Flandina C; Sanguedolce R; Rausa L; D'Alessandro N
    Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):259-72. PubMed ID: 2128759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
    Imondi AR; Della Torre P; Mazué G; Sullivan TM; Robbins TL; Hagerman LM; Podestà A; Pinciroli G
    Cancer Res; 1996 Sep; 56(18):4200-4. PubMed ID: 8797592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitoxantrone: propensity for free radical formation and lipid peroxidation--implications for cardiotoxicity.
    Novak RF; Kharasch ED
    Invest New Drugs; 1985; 3(2):95-9. PubMed ID: 2991163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical, biological and clinical aspects of dexrazoxane and other bisdioxopiperazines.
    Hasinoff BB; Hellmann K; Herman EH; Ferrans VJ
    Curr Med Chem; 1998 Feb; 5(1):1-28. PubMed ID: 9481032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidative and cardioprotective effects of Phyllanthus urinaria L. on doxorubicin-induced cardiotoxicity.
    Chularojmontri L; Wattanapitayakul SK; Herunsalee A; Charuchongkolwongse S; Niumsakul S; Srichairat S
    Biol Pharm Bull; 2005 Jul; 28(7):1165-71. PubMed ID: 15997091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species.
    Kotamraju S; Konorev EA; Joseph J; Kalyanaraman B
    J Biol Chem; 2000 Oct; 275(43):33585-92. PubMed ID: 10899161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.